Blog

No two cases of multiple myeloma are alike, making treatment decisions a challenge – The Mark Foundation for Cancer Research

Photo of David Sontag from themarkfoundation.org

Aug 1, 2024, 07:11

No two cases of multiple myeloma are alike, making treatment decisions a challenge – The Mark Foundation for Cancer Research

The Mark Foundation for Cancer Research shared a post on X, about a recent paper published in npj Digital Medicine:

Joint AI-driven event prediction and longitudinal modeling in newly diagnosed and relapsed multiple myeloma.

Authors: Zeshan Hussain, Edward De Brouwer, Rebecca Boiarsky, Sama Setty, Neeraj Gupta, Guohui Liu, Cong Li, Jaydeep Srimani, Jacob Zhang, Rich Labotka, David Sontag.

No two cases of multiple myeloma are alike, making treatment decisions a challenge - The Mark Foundation for Cancer Research

”No two cases of multiple myeloma are alike, making treatment decisions a challenge. In npj Digital Medicine, ASPIRE awardee David Sontag introduces a machine-learning model to help physicians estimate disease progression and treatment outcomes.

Read more about the work that led to David Sontag’s findings — and the support he received from The Mark Foundation for Cancer Research — in our 2021 Research Spotlight.”

Source: The Mark Foundation for Cancer Research/X

ASPIRE cancer cancer diagnoses cancer treatment Cong Li David Sontag Edward De Brouwer Guohui Liu Jacob Zhang Jaydeep Srimani multiple myeloma Neeraj Gupta npj Digital Medicine OncoDaily Oncology Rebecca Boiarsky Rich Labotka Sama Setty The Mark Foundation for Cancer Research Zeshan Hussain

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage